Stock listing

ILU Stock Price, News, Filings & Events — Illumina, Inc.

Selected listing: ILU · HAN · EUR · DE

This page tracks Illumina, Inc.'s ILU:HAN listing on HAN in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ILU:HAN. ILU:HAN is the stock-level entry point for investors researching Illumina, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Illumina, Inc. is a leading company in the field of genomics, specializing in DNA sequencing and array-based solutions. Based in the United States, Illumina has a market capitalization of approximately $29.37 billion. The company focuses on advancing the understanding of genetics and improving healthcare through innovative technologies.

ILU:HANEURDEUpdated July 24, 2026
Illumina, Inc. logo
Ticker
ILU:HAN
Asset type
Stock
Market cap
$29.37B
Sector
Health Technology
Industry
Medical Specialties
Exchange
HAN
Currency
EUR

Illumina, Inc. ILU:HAN stock context

This page tracks Illumina, Inc.'s ILU:HAN listing on HAN in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ILU:HAN. ILU:HAN is the stock-level entry point for investors researching Illumina, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Illumina, Inc. is a leading company in the field of genomics, specializing in DNA sequencing and array-based solutions. Based in the United States, Illumina has a market capitalization of approximately $29.37 billion. The company focuses on advancing the understanding of genetics and improving healthcare through innovative technologies.

Research Illumina, Inc.

Alternate listings